Research Index
GHK Research Index
PSI surfaces 50 peer-reviewed studies on GHK, prioritized by evidence strength: human clinical research first, then animal studies. The full historical archive is linked below on PubMed.
50 studies
Oral cyclophosphamide as part of the treatment regimen in patients with nonparaneoplastic autoimmune retinopathy secondary to birdshot chorioretinopathy.
Morvey D, Maleki A, Tan PV et al.
Oman J Ophthalmol·2026·Human·PubMed →
Effects of Long-Term Supplementation with Centella asiatica (L.) Urb. Extract (CA-HE50) on Macular Pigment Optical Density: A Randomized, Double-Blind, Placebo-Controlled Trial.
Baek HI, Kim I, Bae J et al.
Nutrients·2026·Human·PubMed →
FOLDABLE CAPSULAR VITREOUS BODY IMPLANTATION IN A PRE-PHTHISICAL EYE: A PRELIMINARY SHORT-TERM CASE REPORT.
Skhirtladze S, Petriashvili G, Nikolaishvili N et al.
Georgian Med News·2026·Human·PubMed →
Imaging the choroidal microvasculature in intensive and high dependency care unit patients: a pilot study.
Cooper GM, Burke J, Hamid C et al.
BMJ Open·2026·Human·PubMed →
ROFI: a deep learning-based ophthalmic sign-preserving and reversible patient face anonymizer.
Habib E, Hajj F
Ann Med Surg (Lond)·2026·Human·PubMed →
Ocular gene therapy mediated by AAV vectors: an overview of immunosuppressive treatments and immunomonitoring of patients involved in clinical trials.
Ren D, Chauveau GA, Cabon E et al.
Prog Retin Eye Res·2026·Human·PubMed →
A Randomized Trial of Tenecteplase in Acute Central Retinal Artery Occlusion.
Ryan SJ, Jørstad ØK, Skjelland M et al.
N Engl J Med·2026·Human·PubMed →
Acute Diffuse Retinal Hemorrhage Following Intravitreal Conbercept Injection: A Case Report and Mechanistic Analysis.
Li N, Ma X, Zhu Y et al.
J Vis Exp·2026·Human·PubMed →
Safety and Efficacy of Orally Administered SJP-0008 in Central Retinal Artery Occlusion: A Phase IIa Randomized Clinical Trial.
Tsuda S, Kunikata H, Hashimoto K et al.
Ophthalmol Sci·2026·Human·PubMed →
Branch retinal vein occlusion as a manifestation of systemic vasculopathy in CADASIL: a multimodal imaging case report.
Aygun FB, Özkorkmaz C, Kadayıfcılar S
Ophthalmic Genet·2026·Human·PubMed →
Oral Tonabersat Connexin-43 Modulator for Diabetic Macular Edema with Good Vision (DRCR Retina Network Protocol AN).
Barkmeier AJ, Vu TP, Elman M et al.
Ophthalmol Sci·2026·Animal·PubMed →
Survey of the current state of intravitreal therapy in Spain.
Garay-Aramburu G, Zarranz-Ventura J, Escobar-Barranco JJ et al.
Arch Soc Esp Oftalmol (Engl Ed)·2026·Animal·PubMed →
Structural dynamics insights into principles underlying the fitness of new broadly potent AAVs.
Johnson ME, Ozturk BE, Tugwell TH et al.
bioRxiv·2026·Animal·PubMed →
Safety profile and signal detection of tadalafil: a real-world analysis based on the Food and Drug adverse event reporting system.
Li J, Li K, Yang S et al.
Sex Med·2026·Animal·PubMed →
Traumatic Glaucoma.
Ng JK, Kaur K
2026·Animal·PubMed →
Early Real-World Outcomes with a Novel Hybrid Full Range of Vision Intraocular Lens.
Valvecchia G, Castro TM, Calero-Vera DE et al.
Medicina (Kaunas)·2026·Animal·PubMed →
EFFICACY OF COMBINED DEXAMETHASONE IMPLANT AND NAVIGATED SUBTHRESHOLD MICROPULSE YELLOW LASER IN DIABETIC MACULAR EDEMA.
Oliverio GW, Meduri A, Ingrande I et al.
Retina·2026·Animal·PubMed →
Ocular complications from glucagon-like peptide-1 receptor agonists: Clinical evidence, potential mechanisms, and clinical recommendations.
Wu TE, Chen HS
J Chin Med Assoc·2026·Animal·PubMed →
Bst2-targeted senotherapy restores visual function by eliminating senescent retinal cells.
Oh JY, Chae JB, Lee HK et al.
Nat Commun·2026·Animal·PubMed →
Living with Retinitis Pigmentosa in Türkiye: Diagnosis, Independence, and Access to Care.
Gürsoy N, Gürsoy E
Healthcare (Basel)·2026·Animal·PubMed →
Ocular Safety of Unilateral Biportal Endoscopic Spinal Surgery: An Optical Coherence Tomography Angiography-Based Analysis.
Gulec A, Eravsar E, Ciftci S et al.
J Clin Med·2026·Animal·PubMed →
mRNA therapy: A novel approach for retinal neurodegenerative diseases.
Zhang B, Tang J, Zhang Q et al.
Neural Regen Res·2026·Animal·PubMed →
Short-Term Effects of Intravitreal Ranibizumab Biosimilar Injections in Patients with Neovascular Age-Related Macular Degeneration on Retinal Nerve Fiber Layer Thickness.
Lee SY, Hwang DD
J Clin Med·2025·Human·PubMed →
Visual Disturbance During Pregnancy: A Case Report of Central Serous Chorioretinopathy.
Mandadi T, Simakurthy S
Cureus·2025·Human·PubMed →
Intravenous alteplase versus oral aspirin for acute central retinal artery occlusion within 4·5 h of severe vision loss (THEIA): a multicentre, double-dummy, patient-blinded and assessor-blinded, randomised, controlled, phase 3 trial.
Préterre C, Gaultier A, Obadia M et al.
Lancet Neurol·2025·Human·PubMed →
Permanent visual impairment following a Behçet's disease flare while on calcitonin gene-related peptide receptor antagonist therapy: a case report.
Khan FA, Malik A, Nelson E et al.
BMC Ophthalmol·2025·Human·PubMed →
Resolution of lamellar macular hole after suprachoroidal triamcinolone injections for cystoid macular edema caused by retinal vein occlusion: A case report.
Abu Ghedda S, Farwati R, Baba M et al.
Medicine (Baltimore)·2025·Human·PubMed →
Intravitreal Povidone-Iodine Injection and Low-Dose Antibiotic Irrigation for Infectious Endophthalmitis: A Retrospective Case Series.
Machida Y, Nakashizuka H, Onoe H et al.
Pharmaceutics·2025·Human·PubMed →
Long-term outcomes of corneal intrastromal lenticule transplantation for necrotic scleral melting and glaucoma: A case report.
Yang J, Li B, Cheng G
Medicine (Baltimore)·2025·Human·PubMed →
Real-World Safety and Effectiveness of Vadadustat in Patients with Chronic Kidney Disease-Related Anemia: Interim Analysis of Postmarketing Surveillance in Japan.
Nangaku M, Sasaki K, Bi J et al.
Adv Ther·2025·Human·PubMed →
[New options determining the success of treatment for neovascular age-related macular degeneration].
Fursova AZ, Nikulich IF, Vasilyeva MA et al.
Vestn Oftalmol·2025·Human·PubMed →
Safety of intravenous thrombolysis in central retinal artery occlusion patients with concomitant acute cerebral infarctions.
Jubran H, Baumgartner P, Jurado EA et al.
J Neurol Sci·2025·Human·PubMed →
Gene therapy in children with AIPL1-associated severe retinal dystrophy: an open-label, first-in-human interventional study.
Michaelides M, Laich Y, Wong SC et al.
Lancet·2025·Human·PubMed →
Safety and Vision Outcomes Following Gene Therapy for Bietti Crystalline Dystrophy: A Nonrandomized Clinical Trial.
Chen X, Liu X, Cui S et al.
JAMA Ophthalmol·2025·Human·PubMed →
Evaluation of Auricular Acupressure on Myopia Prevention among Children Aged 6-12 Years with Pre-Myopia in China: Study Protocol of a Prospective Multi-Center Randomized Controlled Trial.
Wang J, Shi Y, Yan X et al.
Complement Med Res·2025·Human·PubMed →
Patient and practitioner perceptions around use of artificial intelligence within the English NHS diabetic eye screening programme.
Wahlich C, Chandrasekaran L, Chaudhry UAR et al.
Diabetes Res Clin Pract·2025·Human·PubMed →
Subretinal Gene Therapy Drug AGTC-501 for XLRP Phase 1/2 Multicenter Study (HORIZON): 24-Month Safety and Efficacy Results.
Yang P, Birch D, Lauer A et al.
Am J Ophthalmol·2025·Human·PubMed →
Ocular adverse events associated with platins: a disproportionality analysis of pharmacovigilance data and extensive systematic review of case reports.
Hasik PN, Thomas C, Hazarika M et al.
Expert Opin Drug Saf·2025·Human·PubMed →
Effects of traditional Chinese medicine in the treatment of patients with central serous chorioretinopathy: A systematic review and meta-analysis.
Ru S, Sun J, Zhou W et al.
PLoS One·2024·Human·PubMed →
Daily Low-Level Red Light for Spherical Equivalent Error and Axial Length in Children With Myopia: A Randomized Clinical Trial.
Cao K, Tian L, Ma DL et al.
JAMA Ophthalmol·2024·Human·PubMed →
Cardiovascular Outcomes with Intravitreal Anti-Vascular Endothelial Growth Factor Therapy in Patients with Diabetes: A Real-World Data Analysis.
Lai JYM, Riley DR, Anson M et al.
Diabetes Ther·2024·Human·PubMed →
Efficacy of biologically-directed daylight therapy on sleep and circadian rhythm in Parkinson's disease: a randomised, double-blind, parallel-group, active-controlled, phase 2 clinical trial.
Feigl B, Lewis SJG, Burr LD et al.
EClinicalMedicine·2024·Human·PubMed →
THE ROLE OF INTRAVITREAL METHOTREXATE AS AN ADJUNCT TO LOCAL OR SYSTEMIC CORTICOSTEROIDS IN VITRECTOMY FOR RHEGMATOGENOUS RETINAL DETACHMENT AND CHOROIDAL DETACHMENT: A Pilot Study.
Chahar A, Sen A, Shukla D et al.
Retina·2024·Human·PubMed →
Wound healing and postoperative management in paediatric patients following 27-Gauge Transconjunctival Sutureless Vitrectomy for vitreoretinal conditions.
WenTao D, SanMei L, Jie L et al.
Int Wound J·2024·Human·PubMed →
Long-term treatment of chronic kidney disease patients with anemia using hypoxia-inducible factor prolyl hydroxylase inhibitors: potential concerns.
He J, Jia Z, Zhang A et al.
Pediatr Nephrol·2024·Human·PubMed →
Efficacy and Safety of Brolucizumab for Diabetic Macular Edema: The KINGFISHER Randomized Clinical Trial.
Singh RP, Barakat MR, Ip MS et al.
JAMA Ophthalmol·2023·Human·PubMed →
Combining Perfluorobutylpentane (F(4)H(5)) with Glaucoma Drainage Device Implantation for Silicone Oil-Induced Glaucoma: A Pilot Study.
Kandarakis SA, Petrou P, Doumazos S et al.
Turk J Ophthalmol·2023·Human·PubMed →
Retinal Angiomatous Proliferation in a Patient with Retinitis Pigmentosa.
Kiraly P, Downes SM, Fischer MD
Genes (Basel)·2023·Human·PubMed →
Risk analysis for patients with arterial thromboembolic events after intravitreal ranibizumab or aflibercept injections.
Chou YI, Chang HY, Lin MY et al.
Sci Rep·2023·Human·PubMed →
Surgery, Tissue Plasminogen Activator, Antiangiogenic Agents, and Age-Related Macular Degeneration Study: A Randomized Controlled Trial for Submacular Hemorrhage Secondary to Age-Related Macular Degeneration.
Gabrielle PH, Delyfer MN, Glacet-Bernard A et al.
Ophthalmology·2023·Human·PubMed →